As observed by the pioneering neuroscientist Santiago Ramon Cajal, the mature CNS was distinguished from the developing nervous system by the lack of growth and cellular regeneration.
The fixed neuronal population of the adult brain was understood to be necessary to maintain the functional stability of adult brain circuitry.
This explanation has also been offered to account for the lack of endogenous CNS repair following injury or disease.
Ever perceptive, Cajal left open the possibility for future advances to alter this "harsh decree," and in the last several decades, mounting evidence has led to the view of the CNS as a dynamic, plastic organ, endowed with some potential for self-repair and regeneration.
Recent progress in understanding continued neurogenesis in the adult brain has raised hopes that self-renewal leading to structural repair by new neurons may even be possible in the mature CNS.
Nevertheless, under normal conditions, neurogenesis in the adult brain appears to be restricted to the discrete germinal centers: the subventricular zone and the hippocampal dentate gyrus (Figure 1).
While some reports indicate that neurogenesis in the adult CNS may be more widespread and include the cerebral cortex, other reports cast doubt on these observations.
More study is needed to establish the origin, extent, survival, and function of new neurons in these other regions.
Germinal centers in the adult brain.
Neurogenesis in the adult brain is largely confined to two germinal centers: the dentate gyrus and the subventricular zone.
Plasticity in adult neurogenesis
Neurogenesis in the adult brain can be divided into three phases in accordance with the sequence of neurogenesis during CNS development: (a) proliferation, when new cells are generated; (b) migration toward target areas; and (c) terminal differentiation into distinct phenotypes.
It is not yet fully known whether these phases in adult neurogenesis are regulated by the same mechanisms that regulate development, or even whether the same mechanisms regulate neurogenesis in the two adult germinal centers.
Nevertheless, new, functional neurons are generated in these areas, expanding the definition of plasticity in the adult brain to now include cellular addition to circuitry.
New hippocampal neurons may participate in the processing of memory in the hippocampus, while new olfactory bulb neurons appear to participate in processing olfactory input.
Newly generated hippocampal neurons may also contribute to the response of the nervous system to antidepressant administration.
Interestingly, adult neurogenesis is not static, but its rate may fluctuate in response to environmental change, even subtle macro environmental alterations.
Examples of positive regulators of neurogenesis include physical activity, environmental enrichment, caloric restriction, and modulation of neural activity.
The responsiveness of adult neurogenesis to environmental influences suggests that its regulation may be under the control of expressed factors whose level of availability dictates the rate of neurogenesis.
In normal development, a vast repertoire of proneural genes guide stem cells to a neural fate, and these may continue to be expressed or repressed in neurogenic regions of the adult brain in response to stimuli.
Normal CNS development is also guided by the spatial and temporal expression of various trophic or growth factors that guide cell-fate choices and determine the size of the neuronal population.
Indeed, the elevated expression of these factors observed in the mature brain following injury has been thought to represent the brain's attempt to protect injured neurons by activating developmental programs.
In addition to protecting neurons, trophic factors have been shown to stimulate proliferation of adult-derived neural stem cells and to instruct their differentiation.
For example, FGF-2 is a potent mitogen for a variety of cells and modulates embryonic development and differentiation, adult angiogenesis, wound healing, and tissue repair.
In the adult brain, FGF-2 is a survival factor and is neuroprotective against a variety of insults.
Limitations of self-repair by neurogenesis
Various injury models produce increased neurogenesis in germinal centers (Figure 1), but these regions represent a small portion of the total CNS.
What are the prospects for self-repair following injury in other brain structures?
As discussed above, some cortical regions may contain newly generated neurons, but these appear to be limited, transient populations, and their confirmation awaits further study.
Most studies using widespread brain injury models, such as ischemic or traumatic brain injury, have reported neurogenesis only within the germinal structures and not in cortical or striatal structures.
Even when neurogenesis in the striatum (but not cortex) has been reported following ischemic injury, the resulting neurons survive only a short time.
Thus, while a growing number of studies report injury-induced enhancement of neurogenesis, it is clear that under normal circumstances such responses do not lead to complete structural or functional recovery in non-neurogenic brain regions.
As in development, the specific temporal and spatial expression of appropriate trophic factors may be necessary not only to achieve the initial generation of new neural progenitor cells, but also to direct their migration, differentiation, and survival.
Functional integration of new cells into existing circuitry may require additional signals.
In the adult brain, these signals may normally exist only in germinal centers.
Thus the identification and expression of appropriate signals may lead to structural repair in brain structures other than the germinal centers.
Although much has been learned from observing endogenous responses to injuries, it will be necessary to develop targeted therapeutic intervention for brain injury or disease.
At the present time, there are two possible therapeutic strategies to achieve structural brain repair: recruitment and replacement (Figure 2).
Recruitment of endogenous progenitors presents the most elegant strategy for replacing neurons lost to injury or disease.
Proliferation of neural progenitors in germinal centers can be induced by delivery of mitogenic trophic factors, such as FGF-2.
Recruitment of neural progenitors to adjacent brain structures has also been achieved through delivery of other trophic factors, such as brain-derived neurotrophic factor (BDNF), that may instruct cell differentiation.
However, these cells only differentiated following striatal injury, suggesting that additional, unknown signals were required.
Recruitment of peripherally derived progenitor cells, such as blood borne progenitor cells, may provide another cell population for brain repair.
While studies such as those discussed above have generated considerable enthusiasm for the eventual recruitment of endogenous progenitor cells as a therapeutic strategy, the successful development of stem cell recruitment therapy will depend on our ability to manage the proliferation, migration, differentiation, and functional integration of recruited cells.
The first step toward this goal is to investigate the regulation of the events that specify cell fate both in cell culture and in vivo.
For our understanding to advance, it is critical that a wide range of cell types be studied, from embryonic stem cells to adult-derived cells, to test the generality of the regulatory mechanisms.
However, characterizing stem cells will not be sufficient for the development of therapeutic strategies.
It will also be necessary to understand how the brain microenvironment changes as a result of injury, disease, and aging, in order to develop therapies that can recruit endogenous progenitors for structural brain repair.
Therapeutic strategies for brain repair by stem cells.
For brain repair in regions outside of the germinal centers, such as the cerebral cortex, stem cells may contribute to repair through recruitment or replacement.
In the case of recruitment (a), the environment in the non-neurogenic region must be enhanced with appropriate environmental signals to attract endogenous neural stem cells, possibly from the germinal centers, to expand this population of cells, and to instruct their differentiation into appropriate neurons.
This environmental enhancement could most likely be achieved using in vivo gene therapy leading to transgene expression by endogenous cells and may require a precise temporal and spatial delivery of appropriate transgenes to achieve the desired outcome.
In the case of replacement (b.), neural stem cells derived from embryonic, fetal, or adult sources could be expanded in vitro, directed down specific neuronal lineages, and genetically modified to express the necessary environmental signals.
Thus committed to the correct phenotype and expressing necessary environmental signals to ensure their survival, these cells could then be grafted to the target region.
Alternatively (c), the environment could be enhanced by gene delivery before (or possibly after) the grafting of the replacement neural stem cells.
Stem cell recruitment therapy will require targeted and regulated delivery of the key environmental signals or factors to the brain region where repair is needed (Figure 2).
One possible route of delivery is the systemic administration of an identified factor or its synthetic precursor.
This delivery approach requires that the factor cross the blood-brain barrier and reach the target region at the necessary dose.
As factors delivered this way may act upon a wide variety of stem cells, this approach will likely be limited by the nonspecific activation of stem cells in other organ systems or even brain regions other than the intended target.
An alternative strategy is the direct, targeted delivery of the factor by intracranial infusion.
While this approach is suitable for experimental studies, chronic intracranial cannulation of patients will likely present unacceptable health risks.
Perhaps the most promising delivery strategy for managing stem cell recruitment is gene therapy.
While still requiring intracranial injection into the target region, development of viral vectors that can infect postmitotic cells (such as neurons) and that maintain stable, long-term gene expression offer the possibility of requiring only a single delivery episode.
With continued advances in regulation of gene expression, it may be possible to turn transgene expression on during the appropriate time frame, or to shut it down entirely when recruitment is not desired.
By expressing the transgene directly within the targeted cell, it is possible to extend management of therapeutic factors to directly modify the cell through, for example, the expression of intracellular signals or surface receptors.
Finally, it may be possible to construct viral-delivery systems that allow for sequential or simultaneous expression of different environmental signals to accommodate the need to guide recruited stem cells through several stages of cell-fate specification.
Even if all of the key environmental signals necessary to recruit endogenous progenitor cells were determined, the migratory distance from germinal centers would still present an obstacle for repopulation of some brain regions by recruitment.
Another challenge to a recruitment strategy is that the different signals needed to achieve migration followed by differentiation into the desired neuronal phenotype may require distinct spatial and temporal delivery of factors that may be difficult to achieve.
In such cases, an alternative strategy (Figure 2) is to generate a population of defined progenitor cells in culture that could be tailored to a specific neuronal lineage.
These cells would then be grafted into the injured brain region.
Such cell-replacement strategies have been used for some time, with success primarily in experimental models of Parkinson and Huntington diseases.
Replacement of lost or injured neurons may be successful where the environment can specify the appropriate fate of the grafted progenitor cells.
This is true for progenitor cells grafted into germinal centers but not necessarily for other brain regions.
While neonatal brains can readily incorporate grafted progenitor cells, relatively few graft-derived neurons are typically found following intrastriatal or intracortical grafting to the mature brain.
These results suggest that, in the adult brain, non-neurogenic environments may support only limited differentiation.
The state of cell differentiation may also be an important factor, as improved survival with intrastriatal transplantation has been obtained using undifferentiated embryonic stem cells.
Thus success with cell-replacement strategies for structural brain repair may require an appropriate combination of choosing the correct cell-lineage state and creating a supportive brain environment.
The goal of creating a supportive environment for the grafting of replacement cells will likely use the same strategies for trophic factor delivery that are discussed above for recruitment of endogenous cells.
In developing therapies, it will be important to understand the brain's response to trophic factor delivery, irrespective of whether this delivery is intended for recruitment or replacement strategies.
Structural repair in the aging brain
Most animal studies investigating the regulation of neurogenesis and the grafting of neural stem cells have been conducted on neonatal or young adult brains, and much of this work has used injury models that approximate neurodegenerative diseases, such as Alzheimer or Parkinson disease or stroke.
However, the patient populations targeted by these experiments are older, typically at or beyond the sixth decade of life.
Does the aging brain provide the same environment for neurogenesis as does the young adult brain?
In aged rodents, there are significantly fewer new neurons generated in the germinal centers.
However, this age-related decline can be reversed, at least in the hippocampus, by environmental enrichment, N-methyl-D-aspartate receptor antagonist treatment, or reduction of corticosteroid levels.
Reduction of corticosteroid levels may not be a useful therapeutic approach, as lowering levels also leads to neuronal cell death.
The reversal of age-related decline in neurogenesis suggests that there is no intrinsic limitation with aging, and that, instead, the environment may change to provide less support for neurogenesis with aging.
One possibility is that the age-related decline in neurogenesis results from reduced trophic factor levels.
This possibility is supported by the reported enhancement of neurogenesis in aged rodent brains following exogenous delivery of IGF-I, or of FGF-2 or heparin binding EGF-like growth factor.
Furthermore, pretreatment with trophic factors improved the survival of fetal neurons grafted to the aged hippocampus, suggesting that the availability of trophic factors in the aged hippocampus may be limited.
An age-related limitation in the brain environment is also suggested by the clinical experience with fetal-tissue grafts to the brains of Parkinson patients.
It is showed that the prospects for clinical improvement decrease as a function of patient age and that fetal transplants may contribute to the development of persistent dyskinesia.
Another recent report found no improvement in patient outcome following fetal-neuron transplantation to Parkinson patients.
Thus, stem cell therapies for the aged brain may hold great clinical potential, but the capacity of the aged brain to support the recruitment or survival of transplanted stem cells remains to be determined.
As discussed above, it is likely that the environment of the aged brain will need to be augmented, and investigation into regulation of the capacity of the aged brain to support structural brain repair should receive high priority.
It is possible in certain circumstances to recruit neural stem cells in the adult brain to contribute new neurons into areas depleted by experimental injury.
Much work is required to elucidate the signals involved in recruiting stem cells for this purpose.
Not only must environmental changes resulting from disease pathology or injury response be better understood, but also the capacity of undifferentiated stem cells to respond to the spatial and temporal presentation of these signals must be determined.
The prospects for developing therapeutic applications from advancing our understanding of how stem cell fate is managed relies on continued and unfettered basic research into fundamental properties of embryonic and adult-derived stem cells.
Finally, age related changes in the brain's capacity to support both endogenous and grafted neural stem cells need to be better understood to advance the possible harnessing of neurogenesis for structural brain repair.